Human papillomavirus (HPV) vaccination has revolutionized cervical cancer prevention.
Clinical trials confirm that the quadrivalent (HPV types 6, 11, 16, 18) and bivalent (HPV types …

The challenge of vaccine hesitancy, a growing global concern in the last decade, has been
aggravated by the COVID-19 pandemic. The need for monitoring vaccine sentiments and …

Abstract In 2019, the World Health Organization (WHO) named “Vaccine Hesitancy” one of
the top 10 threats to global health. Shortly afterward, the COVID‐19 pandemic emerged as …

ABSTRACT HPV vaccine hesitancy in Asia is unique compared to Western countries due to
multidimensional social-cultural norms that influence beliefs regarding vaccination. Reviews …

Cervical cancer (CC) remains a current global issue, with> 90% of cervical cancer cases
being attributed to human papilloma virus (HPV). The highest burden of cervical cancer is …

Background It has been proven that vaccination is effective against Human Papillomavirus
(HPV) infections, genital warts, and pre-cancerous and cancerous cervical lesions …

Introduction: Human papillomavirus infections are the most prevalent sexually transmitted
disease among women worldwide. Cervical cancer is the second-most frequent disease …

Little is known regarding Chinese mothers' intention to vaccinate their daughters against
human papillomavirus (HPV) since the HPV vaccine was approved for use in China in 2016 …

Background Human papillomavirus vaccine uptake among school girls in Ethiopia was still
low and uptake was majorly related to perception regarding the vaccine. This study explored …

There is currently a lack of sufficient data on human papillomavirus (HPV)-attributable
cervical carcinoma in China. Accordingly, we aimed to determine the prevalence and …